(Stroke. 1996;27:2251-2255.)
© 1996 American Heart Association, Inc.
Articles |
the Departments of Neurological Sciences (E.M.Z., G.M., M.S.) and Clinical Medicine (S. De C., D.C.), University "La Sapienza," and the Department of Organ and System Pathophysiology, Istituto Superiore di Sanita (F.C.), Rome, Italy.
Correspondence to Prof Elietta M. Zanette, Department of Neurological Sciences, University "La Sapienza," Viale dell'Universita, 30, 00185 Rome, Italy.
| Abstract |
|---|
|
|
|---|
Methods We selected 38 cerebrovascular patients (21 men, 17 women) with positive contrast study for PFO on transesophageal echocardiography. Patients underwent a TCD with bilateral monitoring of the middle cerebral arteries (MCAs) and injection of a contrast solution. The injection was repeated (1) during normal breathing (basal conditions); (2) before Valsalva maneuver (VM); (3) during VM; (4) immediately after VM; and (5) during cough. The latency time and the total number of microbubbles for each side were recorded.
Results TCD found positive results for PFO in 30 patients. Twenty were positive even during basal conditions. The number of positive cases varied according to the timing of the VM in relation to the contrast injection: 28, 25, and 27 cases were positive when the injection was performed before, during, and after VM, respectively, while 26 were positive during cough. There were significant differences in the number of microbubbles in the MCAs between the procedures (P<.001, ANOVA): the highest number was detected in the injection before VM and the lowest number during basal conditions (P<.001, Wilcoxon's test with Bonferroni's correction). The latency time was significantly shorter when the injection followed VM.
Conclusions The injection performed before VM appeared to be the most effective TCD procedure in determining the transit of microbubbles through a PFO and subsequently in the MCAs.
Key Words: echocardiography, transesophageal foramen ovale, patent transcranial Doppler ultrasonics
| Introduction |
|---|
|
|
|---|
TEE, although a semi-invasive procedure, has been confirmed as the method of choice for the detection of a right-to-left shunt, particularly during provocative conditions such as the VM or cough.5 6 7
Recent studies have proposed TCD, which is able to detect air or contrast microbubbles passing through the intracranial arteries, as an alternative noninvasive technique for the detection of an intracardiac right-to-left shunt.8 9 10 11 12 13 14 However, the most effective provocative maneuver to raise the right atrial pressure to induce the right-to-left shunt has not yet been established, and there is no agreement on the most effective timing between the VM and the injection of ultrasound contrast medium. The latency time of microbubble detection in the MCA from the injection is also still a matter of debate (Table 1
).
|
The aim of our study was (1) to compare the efficacy of different maneuvers and of different timing of the contrast injection in determining the transit of microbubbles in the middle cerebral arteries and (2) to compare the latency times of the various provocative procedures to assess the optimum observation period.
| Subjects and Methods |
|---|
|
|
|---|
A contrast TCD examination was performed within 24 hours of the TEE. All patients had given their informed consent to this study.
Echocardiographic Protocol
All patients underwent transesophageal studies with a 5-MHz biplane or 5/3.5-MHz multiplane transducers, shortly after a transthoracic examination. The TEE was performed with the patient in the left lateral decubitus position, after a fast of more than 4 hours, with the use of topical hypopharyngeal anesthesia with 10% lidocaine spray. After a complete anatomic and functional examination to search for cardiac sources of emboli, the probe was positioned with the scanning plane at the level of the fossa ovalis. Color-flow mapping before the contrast study was performed in an attempt to detect left-to-right and/or right-to-left shunts. The contrast study, during both TTE and TEE, was performed with a mixture of saline solution (9 mL) and air (1 mL), agitated between two 10-mL syringes, connected by a three-way stopcock. When ready, the solution was immediately injected in 2 to 3 seconds into an antecubital vein to obtain a bolus of air microbubbles.8 This procedure was performed during both normal breathing and VM. The patient was asked to start the VM at the time of injection and to release the strain after the complete opacification of the right atrium by contrast solution. All echocardiographic examinations were recorded on a super-VHS videotape and independently reviewed by two cardiologists. The contrast study was considered positive if three or more microbubbles appeared in the left atrium within three cardiac cycles after complete opacification of the right atrium.7 The maximum number of microbubbles shunted in the left atrium at rest or during VM was counted off-line in a single freeze-frame. Contrast studies during the VM were repeated if a first injection yielded a negative or a questionable result. Echocardiographic measurements of the functional characteristics of PFO were blindly reviewed by two cardiologists (S. De C. and D.C.). In a previous report by these cardiologists, no significant interobserver variability was found in the TEE measurements, with a high agreement in grading PFO shunting both at rest (Spearman's r=.97) and during VM (Spearman's r=.96).15
Contrast TCD Protocol
Both MCAs were simultaneously monitored by means of an elastic headband, supporting a pair of 2-MHz probes. A special software for emboli count was used to record and count high-intensity transient signals from each MCA.
The preparation of the contrast solution was the same as that of the contrast echocardiography. The appearance of microbubbles in the MCAs was automatically recorded by the equipment together with the time, side, and intensity (in decibels) of each event (Figure
). The test was considered positive when at least one microbubble was detected within 22 seconds of the contrast injection.13
|
After the injection at rest, during normal breathing (BC), the test was repeated in association with the following provocative maneuvers, with a 2-minute interval between each procedure: (1) before a 10-second VM (IBVM); (2) during a 10-second VM, starting the injection at the 5th second (IDVM); (3) immediately after a VM (IAVM); and (4) during repeated series of 3 to 5 rapid and successive coughs, prolonged for at least 20 seconds.16
For each procedure, we considered both the time interval (in seconds) and the number of cardiac cycles between the start of the contrast injection and the appearance of the first microbubble in each side (latency time) and the total number of microbubbles for each side during an observation period of 20 seconds after the first microbubble was detected.
All the contrast studies with provocative maneuvers were repeated at least twice when a result was negative or questionable.
All the patients were able to perform an effective VM, preliminarily evaluated, without contrast injection, by a mean flow velocity reduction of at least 25% in phase II.17
To assess the reproducibility of the microbubble count in the MCAs and of the latency time recording, we repeated the contrast injection during BC in 10 TCD-positive patients.
Statistical Analysis
Data were analyzed by Friedman's nonparametric ANOVA because of the nonnormal distribution of data and the presence of cutoff values for latency times. The
2 partitioning of the overall Friedman's
2 was used to assess the main effects of maneuvers and side and the effect of their interaction. In view of the nonsignificant effect of side and of maneuverxside, data collected on the two sides were collapsed; the mean for the number of microbubbles and the minimum for the latency time were used. Wilcoxon's nonparametric test for paired data with Bonferroni's correction was used for multiple comparisons. The reproducibility of the microbubble count and of latency time recording were analyzed by means of Wilcoxon's test.
| Results |
|---|
|
|
|---|
The timing of the VM in relation to the contrast injection determined a different number of positive cases: the IBVM detected 28 of 30 positive patients, the IDVM 25 of 30, and the IAVM 27 of 30. Coughing was effective in 26 cases. All the patients were able to cooperate adequately when performing the various provocative maneuvers. Two patients were found to be positive for IAVM and cough but negative for IBVM and IDVM, while 3 other patients were positive for only IBVM and negative for the other procedures. These 5 patients with discrepancies between the procedures all showed fewer than 10 microbubbles in the MCAs, and 3 of them were only unilaterally positive at TCD.
In the 20 patients who were positive during BC, the mean number of microbubbles detected in the MCAs was 5.8±12.6 for the right side and 5.7±9.3 for the left side (13 patients showed fewer than 10 microbubbles in each MCA). The mean latency time between the injection and the appearance of the first microbubble was 9.7±4.1 seconds (Table 2
).
|
In 10 of these 20 patients who were positive for PFO in BC, the repetition of the contrast solution injection did not reveal any significant difference between the two tests, either in the number of microbubbles in transit through the MCAs (P=.37, Wilcoxon) or in the latency time (P=.55, Wilcoxon).
The different timing between the VM and the injection determined differences in the number of microbubbles in transit through the MCAs (as shown in Table 2
). The Friedman ANOVA showed that these differences between procedures were statistically significant (
2=86.23, df=4, P<.001), whereas no significant differences were found between the two sides, either globally or separately within each procedure. Wilcoxon's test for paired data showed that the number of microbubbles detected during BC was significantly lower than that obtained with each of the provocative maneuvers (BC versus IBVM, P<.001; BC versus IDVM, P<.005; BC versus IAVM and BC versus cough, P<.05). Differences between provocative maneuvers were also found to be significant, insofar as IBVM determined a significantly higher number of microbubbles than any of the other procedures (IBVM versus IAVM and IBVM versus cough, P<.001; IBVM versus IDVM, P<.05).
The latency time between contrast injection and detection of the first microbubble in the MCAs varied significantly between the different procedures (Friedman
2=20.97, df=4, P<.001 for latency time expressed in seconds; Friedman
2=9.72, P<.05 for number of cardiac cycles) but did not differ between the two sides, either globally or within each procedure. Wilcoxon's test for paired data showed that the latency time for BC was significantly higher than that measured in IAVM (P<.01 for seconds, P<.05 for cardiac cycles), whereas the other provocative maneuvers gave intermediate values. For detailed data, see Table 2
.
| Discussion |
|---|
|
|
|---|
Notwithstanding TCD accuracy in the diagnosis of PFO, which ranges from 68% to 100% in the literature8 9 10 11 12 13 14 (TCD sensitivity was 78.9% in our study), 8 of our TEE-positive patients showed negative results at TCD despite all provocative maneuvers. These 8 patients did not show a severe degree of right-to-left shunt: all of them were positive only at VM, during which they showed the transit of fewer than 20 microbubbles in the left atrium. The fact that we sometimes detected microbubbles only unilaterally in some of the tests suggests that the simultaneous exploration of both MCAs might have increased TCD sensitivity in our study. The reproducibility of TCD measurements of both microbubbles and latency times in a subgroup of 10 patients was good, with no difference found between repeated measurements.
A possible explanation for the relatively high number of patients (20) with positive results for PFO even under BC may be that although the mean left atrial pressure is normally higher than the right, a transient inversion of this pressure gradient may occur during normal breathing, permitting a right-to-left shunt if a good interatrial functional communication is present.18 This hypothesis is supported by the observation that in normal individuals the interatrial septum bows toward the left atrium in midsystole during mechanical expiration.19
However, which provocative maneuver is preferable (VM or cough) has not yet been sufficiently investigated. Stoddard et al16 reported that the cough test is superior to VM in diagnosing a PFO during contrast TEE, although this observation has not been confirmed for TCD. Most of the authors used VM as a provocative test, while both VM and cough were used in only one study, which did not mention whether any difference between these provocative maneuvers had been found.12 Our results showed that cough detected a slightly lower number of positive patients than VM (26/30).
The timing of the contrast solution injection in relation to VM is also still a matter of debate. Most of the authors injected the contrast solution (usually agitated saline) during VM8 9 10 11 ; other authors did it immediately before VM,12 13 and only one at the end of VM14 ; in none of these studies were these procedures compared. We made such a comparison in our study and found that the highest number of PFO-positive patients, confirmed by TEE, were detected when the contrast solution was injected before VM (IBVM=28/30), followed by IAVM (27/30) and IDVM (25/30).
The higher number of positive patients for IBVM can be explained by the fact that this procedure determines the highest number of microbubbles in transit through the MCAs. The difference in the number of microbubbles between the various procedures was confirmed by the statistical analysis. The discrepancy in 5 cases between the different procedures may be due to the ubiquitous and random distribution in the systemic circulation of a small number of shunting microbubbles.12
We believe it is reasonable to assume that the higher the number of contrast microbubbles shunting through a PFO, the higher the probability of correctly diagnosing the interatrial communication. From a theoretical point of view, these results can be explained by the hemodynamic variations that take place during VM, as reported by several studies on the physiology of VM.20 21 22 At the beginning of VM, the rise in intrathoracic pressure results in (1) a relevant increase in the right atrium and pulmonary artery pressure, with a reduction in the flow and velocity of the pulmonary circulation,21 22 and (2) a reduced venous return toward the heart.22
When the Valsalva strain is released, the sharp increase in the venous return to the heart, while the pulmonary district is still deplete, leads to a further rise in right atrial pressure, which can briefly exceed left atrial pressure, thus permitting a right-to-left shunt if a PFO is present, as reported by Langholz et al23 in a combined study with TEE and cardiac catheterization.
The injection performed immediately before VM should allow the microbubbles to reach the right atrium as a bolus just when the pulmonary circulation slows down. This means the microbubbles have more time to reach and accumulate in the right atrium during VM, so that they can then cross the PFO at the release of the Valsalva strain. If the contrast injection is performed during VM (IDVM), fewer microbubbles can accumulate in the right atrium because of the shorter duration of the slower pulmonary circulation. If the injection is given after VM (IAVM), the number of microbubbles should, in theory, be even smaller in the right atrium, given that they mix with the increased incoming venous flow and fewer microbubbles would therefore cross the PFO. The injection during coughing should be similar to the post-VM injection condition, given that cough represents a sudden, transient increase in the right atrial pressure while microbubbles are reaching the right heart without being concentrated by the VM.
The slowing effect of VM on the circulation and its subsequent acceleration at the release of VM are evident if we consider the latency time for each procedure. The longest mean latency time was obtained in BC, followed by IBVM, cough, and IDVM, while the shortest latency time was measured with IAVM (significantly different from BC), which is influenced only by the post-VM acceleration of the circulation.
Although there were no substantial differences in the number of PFO-positive patients between the various procedures, the contrast injection before VM determined the passage of a significantly higher number of microbubbles through the MCAs. Consequently, this TCD procedure seems to be preferable in assessing a right-to-left shunt in PFO-positive patients. Coughing, on the other hand, may be an alternative provocative maneuver that can be easier for patients who cannot perform the VM correctly.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received June 11, 1996; revision received July 26, 1996; accepted August 25, 1996.
| References |
|---|
|
|
|---|
2. Lechat PH, Mas JL, Lascault G, Loron PH, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318,18:1148-1152.
3. Webster MWI, Smith HJ, Sharpe DN, Chancellor AM, Swift DL, Bass NM, Glasgow GL. Patent foramen ovale in young stroke patients. Lancet. 1988;2:11-12.[Medline] [Order article via Infotrieve]
4. Pearson AC, Nagelhout D, Castello R, Gomez CR, Labovitz AJ. Atrial septal aneurism and stroke: a transesophageal echocardiographic study. Am J Coll Cardiol. 1991;18:1223-1229.[Abstract]
5. Lynch JJ, Schuchard GH, Gross CM, Wann LS. Prevalence of right-to-left shunting in the healthy population: detection by Valsalva maneuver contrast echocardiography. Am J Cardiol. 1984;53:1478-1480.[Medline] [Order article via Infotrieve]
6. Siostrzonek P, Zangeneh M, Gossinger H, Lang W, Rosenmayr G, Heinz G, Stumpflen A, Zeiler K, Schwarz M, Mosslacher H. Comparison of transesophageal and transthoracic contrast echocardiography for detection of a patent foramen ovale. Am J Cardiol. 1991;68:1247-1249.[Medline] [Order article via Infotrieve]
7.
Lee RJ, Bartzokis T, Yeoh T, Grogin HR, Choi D, Schittger I. Enhanced detection of intracardiac sources of cerebral emboli by transesophageal echocardiography. Stroke. 1991;22:734-739.
8.
Teague SM, Sharma MK. Detection of paradoxical cerebral echo contrast embolization by transcranial Doppler ultrasound. Stroke. 1991;22:740-745.
9. Nemec JJ, Marwick TH, Lorig RJ, Davison MB, Chimowitz MI, Litowitz H, Salcedo EE. Comparison of transcranial Doppler ultrasound and transesophageal contrast echocardiography in the detection of interatrial right-to-left shunts. Am J Cardiol. 1991;68:1498-1502.[Medline] [Order article via Infotrieve]
10. Karnik R, Stolberger C, Valentin A, Winkler WB, Slany J. Detection of patent foramen ovale by transcranial contrast Doppler ultrasound. Am J Cardiol. 1992;69:560-562.[Medline] [Order article via Infotrieve]
11.
Di Tullio M, Sacco RL, Venketasubramanian N, Sherman D, Mohr JP, Homma S. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke. 1993;24:1020-1024.
12. Job FP, Ringelstein EB, Grafen Y, Flachskampf FA, Doherty C, Stockmanns A, Hanrath P. Comparison of transcranial contrast Doppler sonography and transesophageal contrast echocardiography for the detection of patent foramen ovale in young stroke patients. Am J Cardiol. 1994;74:381-384.[Medline] [Order article via Infotrieve]
13. Jauss M, Kaps M, Keberle M, Haberbosch W, Dorndorf W. A comparison of transesophageal echocardiography and transcranial Doppler sonography with contrast medium for detection of patent foramen ovale. Stroke. 1994;25:1265-1267.[Abstract]
14. Anzola GP, Renaldini E, Magoni M, Costa A, Cobelli M, Guindani M. Validation of transcranial Doppler sonography in the assessment of patent foramen ovale. Cerebrovasc Dis. 1995;5:194-198.
15. De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Beni S, Magni G, Fedele F. Right-to-left shunt at rest and increased mobility of atrial septum identify a subgroup of PFO patients at higher risk for recurrent embolism. J Am Coll Cardiol. 1996;27(suppl A):161A. Abstract.
16. Stoddard MF, Keedy DL, Dawkins PR. The cough test is superior to the Valsalva maneuver in the delineation of right-to-left shunting through a patent foramen ovale during contrast transesophageal echocardiography. Am Heart J. 1993;125:185-189.[Medline] [Order article via Infotrieve]
17.
Tiecks FP, Lam AM, Matta BF, Strebel S, Douville C, Newell DW. Effects of the Valsalva maneuver on cerebral circulation in healthy adults: a transcranial Doppler study. Stroke. 1995;26:1386-1392.
18.
Belz GG, Bernuth GV, Hofstetter R, Rohl D, Stauch M. Temporal sequence of right and left atrial contractions during spontaneous sinus rhythm and paced left atrial rhythm. Br Heart J. 1973;35:284-287.
19. Kusumoto FM, Muhiudeen IA, Kuecherer HF, Cahalan MK, Schiller NB. Response of the interatrial septum to transatrial pressure gradients and its potential for predicting pulmonary capillary wedge pressure: an intraoperative study using transesophageal echocardiography in patients during mechanical ventilation. J Am Coll Cardiol. 1993;21:721-728.[Abstract]
20. De Burgh Daly M. Interactions between respiration and circulation. In: Handbook of Physiology: The Respiratory System II. Bethesda, Md: American Physiological Society; 1986;2:569-570.
21. Goldberg H, Elisberg EI, Katz LN. The effects of the Valsalva-like maneuver upon the circulation in normal individuals and patients with mitral stenosis. Circulation. 1952;5:38-47.[Medline] [Order article via Infotrieve]
22.
Korner PI, Tonkin AM, Uther JB. Reflex and mechanical circulatory effects of graded Valsalva maneuvers in normal man. J Appl Physiol. 1976;40:434-440.
23. Langholz D, Louie EK, Konstadt SN, Rao TLK, Scanlon PJ. Transesophageal echocardiographic demonstration of distinct mechanisms for right to left shunting across a patent foramen ovale in the absence of pulmonary hypertension. J Am Coll Cardiol. 1991;18:1112-1117.[Abstract]
This article has been cited by other articles:
![]() |
M. Del Sette, L. Dinia, and C. Gandolfo Response to Letter by Topcuoglu Stroke, August 1, 2008; 39(8): e125 - e125. [Full Text] [PDF] |
||||
![]() |
M. Del Sette, L. Dinia, D. Rizzi, A. Sugo, B. Albano, and C. Gandolfo Diagnosis of Right-to-Left Shunt With Transcranial Doppler and Vertebrobasilar Recording Stroke, August 1, 2007; 38(8): 2254 - 2256. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Kassab, A. Majid, M. U. Farooq, H. Azhary, L. A. Hershey, E. M. Bednarczyk, D. F. Graybeal, and M. D. Johnson Transcranial Doppler: An Introduction for Primary Care Physicians J Am Board Fam Med, January 1, 2007; 20(1): 65 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Engelhardt, W. Folkers, C. Brenke, M. Scholz, A. Harders, H. Fidorra, and K. Schmieder Neurosurgical operations with the patient in sitting position: analysis of risk factors using transcranial Doppler sonography Br. J. Anaesth., April 1, 2006; 96(4): 467 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Schuchlenz, G.P. Anzola, E. Morandi, F. Casilli, and E. Onorato Contrast Ultrasound Techniques in the Detection and Quantification of Patent Foramen Ovale: Myth Versus Reality * Response: Stroke, December 1, 2004; 35(12): 2755 - 2756. [Full Text] [PDF] |
||||
![]() |
N. Uzuner, S. Horner, G. Pichler, D. Svetina, and K. Niederkorn Right-to-Left Shunt Assessed by Contrast Transcranial Doppler Sonography: New Insights J. Ultrasound Med., November 1, 2004; 23(11): 1475 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Devuyst, B. Piechowski-Jozwiak, T. Karapanayiotides, J.-W. Fitting, V. Kemeny, L. Hirt, L. A. Urbano, P. Arnold, G. van Melle, P.-A. Despland, et al. Controlled Contrast Transcranial Doppler and Arterial Blood Gas Analysis to Quantify Shunt Through Patent Foramen Ovale Stroke, April 1, 2004; 35(4): 859 - 863. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J Landzberg and P. Khairy Indications for the closure of patent foramen ovale Heart, February 1, 2004; 90(2): 219 - 224. [Full Text] [PDF] |
||||
![]() |
D. W. Droste, S. Lakemeier, T. Wichter, J. Stypmann, R. Dittrich, M. Ritter, M. Moeller, M. Freund, and E. B. Ringelstein Optimizing the Technique of Contrast Transcranial Doppler Ultrasound in the Detection of Right-to-Left Shunts Stroke, September 1, 2002; 33(9): 2211 - 2216. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Arquizan, J. Coste, P.-J. Touboul, and J.-L. Mas Is Patent Foramen Ovale a Family Trait? : A Transcranial Doppler Sonographic Study Stroke, July 1, 2001; 32(7): 1563 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. De Castro, D. Cartoni, M. Fiorelli, M. Rasura, A. Anzini, E. M. Zanette, M. Beccia, C. Colonnese, F. Fedele, C. Fieschi, et al. Morphological and Functional Characteristics of Patent Foramen Ovale and Their Embolic Implications Stroke, October 1, 2000; 31(10): 2407 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Droste, K. Silling, J. Stypmann, M. Grude, V. Kemeny, T. Wichter, K. Kuhne, and E. B. Ringelstein Contrast Transcranial Doppler Ultrasound in the Detection of Right-to-Left Shunts : Time Window and Threshold in Microbubble Numbers Stroke, July 1, 2000; 31(7): 1640 - 1645. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Droste, J.-U. Kriete, J. Stypmann, M. Castrucci, T. Wichter, R. Tietje, B. Weltermann, P. Young, and E. B. Ringelstein Contrast Transcranial Doppler Ultrasound in the Detection of Right-to-Left Shunts : Comparison of Different Procedures and Different Contrast Agents Stroke, September 1, 1999; 30(9): 1827 - 1832. [Abstract] [Full Text] [PDF] |
||||
![]() |
F J Kirkham Stroke in childhood Arch. Dis. Child., July 1, 1999; 81(1): 85 - 89. [Full Text] |
||||
![]() |
J. J. Schwarze, D. Sander, C. Kukla, I. Wittich, V. L. Babikian, and J. Klingelhofer Methodological Parameters Influence the Detection of Right-to-Left Shunts by Contrast Transcranial Doppler Ultrasonography Stroke, June 1, 1999; 30(6): 1234 - 1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Droste, M. Reisener, V. Kemeny, R. Dittrich, G. Schulte-Altedorneburg, J. Stypmann, T. Wichter, and E. B. Ringelstein Contrast Transcranial Doppler Ultrasound in the Detection of Right-to-Left Shunts : Reproducibility, Comparison of 2 Agents, and Distribution of Microemboli Stroke, May 1, 1999; 30(5): 1014 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ay, F. S. Buonanno, S. A. Abraham, J. P. Kistler, and W. J. Koroshetz An Electrocardiographic Criterion for Diagnosis of Patent Foramen Ovale Associated With Ischemic Stroke Stroke, July 1, 1998; 29(7): 1393 - 1397. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |